Cubist Systematic Strategies, LLC Eye Point Pharmaceuticals, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.8 Billion
- Q3 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 31,971 shares of EYPT stock, worth $295,092. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,971
Previous 476,250
93.29%
Holding current value
$295,092
Previous $4.14 Million
93.85%
% of portfolio
0.0%
Previous 0.03%
Shares
13 transactions
Others Institutions Holding EYPT
# of Institutions
150Shares Held
58MCall Options Held
177KPut Options Held
263K-
Cormorant Asset Management, LP Boston, MA8.33MShares$76.8 Million4.66% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$47.8 Million1.63% of portfolio
-
Franklin Resources Inc San Mateo, CA4.01MShares$37 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.79MShares$35 Million0.06% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$34.7 Million0.0% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $314M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...